--- title: "Xingqi Pharmaceutical: SQ-22031 eye drops obtain Phase I clinical research report" type: "News" locale: "en" url: "https://longbridge.com/en/news/242390844.md" description: "Xingqi Pharmaceutical announced that its developed SQ-22031 eye drops have obtained the Phase I clinical research report, evaluating its safety, tolerability, and pharmacokinetics in healthy subjects. The indication for this drug is neurotrophic keratitis, and currently, there are no similar drugs approved for market" datetime: "2025-05-29T11:42:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/242390844.md) - [en](https://longbridge.com/en/news/242390844.md) - [zh-HK](https://longbridge.com/zh-HK/news/242390844.md) --- # Xingqi Pharmaceutical: SQ-22031 eye drops obtain Phase I clinical research report According to the Zhitong Finance APP, Xingqi Pharmaceutical (300573.SZ) announced that its developed SQ-22031 eye drops have recently received the clinical research report for the "Evaluation of the Safety, Tolerability, and Pharmacokinetics of SQ-22031 Eye Drops in Healthy Subjects in a Single/Multiple Dose, Single-Center, Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial." The indication for the SQ-22031 eye drops announced this time is neurotrophic keratitis. As of the date of this announcement, there are no approved drugs of the same variety listed on the National Medical Products Administration website ### Related Stocks - [300573.CN](https://longbridge.com/en/quote/300573.CN.md) ## Related News & Research - [Advance Metals Moves Towards Full Ownership of Myrtleford and Beaufort Gold Projects](https://longbridge.com/en/news/287147459.md) - [Coffee Prices Rebound on Technical Short-Covering](https://longbridge.com/en/news/286941721.md) - [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md) - [BRIEF-Mexico's Fibra Next Extends, Raises Public Offer For Fibra Macquarie](https://longbridge.com/en/news/287128862.md) - [Alibaba unveils new Qwen model, custom chips in bid to become China’s AI factory](https://longbridge.com/en/news/287044112.md)